Patents matching “The United States of America as Represented By The Secretary of the Department of Health and Human”

US 9044457

Anti-DR4 agonist antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

US 9012618

Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

US 9005631

Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 14, 2015 · Expires Apr 9, 2035

US 9006203

Method of reducing inflammatory infiltration in subjects with inflammatory lung disease

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 14, 2015 · Expires Apr 9, 2035

US 9000141

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 7, 2015 · Expires Apr 2, 2035

US 8957015

Tumor suppressor gene p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 17, 2015 · Expires Feb 12, 2035

US 8940700

E-selectin compositions and use thereof for inducing E-selectin tolerance

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jan 27, 2015 · Expires Jan 22, 2035

US 8926986

Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

US 8927030

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

US 8921071

Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

US 8911728

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

US 8906358

Leishmania challenge model

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 9, 2014 · Expires Dec 4, 2034

US 8901093

Custom vectors for treating and preventing pancreatic cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 2, 2014 · Expires Nov 27, 2034

US 8895521

Methods and compositions for the treatment of uveitis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 25, 2014 · Expires Nov 20, 2034

US 8877213

Live attenuated Leishmania vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

US 8877765

Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

US 8877199

B cell surface reactive antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

US 8871191

Use of IL-15 preparations to treat lymphopenia

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

US 8865880

Identification of a novel BHD gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

US 8852605

Vibrio cholerae O139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

US 8846051

Modulation of replicative fitness by deoptimization of synonymous codons

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8846056

Anti-RSV immunogens and methods of immunization

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8841266

Pharmaceutical composition and method for regulating abnormal cellular proliferation

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Sep 23, 2014 · Expires Sep 18, 2034

US 8835378

Multi-domain amphipathic helical peptides and methods of their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034